Xiaoyu Liang

9PUBLICATIONS
58CO-AUTHORS
Molecular targetsPredictive and prognostic markersMicro- and nanosystemsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 14, 2026
MYO1G Facilitates Caveolin 1-Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy.

|Apr 15, 2026
Multi-omic characterization of nasopharyngeal carcinoma delineates the subtype-specific landscape of response to induction chemotherapy.

|Mar 10, 2026
TOLLIP targets GSDME-NT-carrying endocytic vesicles for autophagy to regulate pyroptosis and chemotherapy efficacy.

Zhimin Xu, Zhe Li, Zhenji Deng

|Mar 05, 2026
Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity.

Zhenji Deng, Chuqing Zhang, Hanmiao Wei

|Aug 04, 2025
PROCR diminishes the efficacy of radiation by impairing T-cell-mediated antitumour immunity.

Weipeng Chen, Chuqing Zhang, Zhe Li

|Mar 04, 2025
Methionine metabolite spermidine inhibits tumor pyroptosis by enhancing MYO6-mediated endocytosis.

Jiawei Wu, Cong Ding, Chuqing Zhang

Pageof 2

Frequent Collaborators

7 joint publications

Jun Ma

3 joint publications

Zhenji Deng

3 joint publications

Zhe Li

3 joint publications

Linglong Tang